Pharmacokinetics and safety of golimumab, a fully human anti-TNF-α monoclonal antibody, in subjects with rheumatoid arthritis

Authors :: Zhou, Honghui
Jang, Haishan
Fleischmann, Roy M.
Bouman-Thio, Esther
Xu, Zhenhua
Marini, Joseph C.
Pendley, Charles
Jiao, Qun
Shankar, Gopi
Marciniak, Stanley J.
Cohen, Stanley B.
Rahman, Mahboob U.
Baker, Daniel
Mascelli, Mary Ann
Davis, Hugh M.
Everitt, Daniel E.
Source :: Journal of Clinical Pharmacology. March 2007, Vol. 47 Issue 3, p383, 14 p.
Publication Year :: 2007
Abstract: Golimumab is a fully human antitumor necrosis factor alpha (TNF-α) monoclonal antibody that is being developed for intravenous and subcutaneous administration. To assess the pharmacokinetics and safety of the intravenous [...]

Subjects :: Pharmacokinetics -- Analysis -- Usage
Monoclonal antibodies -- Usage -- Complications and side effects
Rheumatoid arthritis -- Care and treatment -- Complications and side effects
Health
Care and treatment
Usage
Analysis
Complications and side effects

Tools